CLINICAL TRIALS

Micromet is currently enrolling patients in BLAST, a pivotal study of the Company's lead product candidate blinatumomab in patients with ALL.
Learn more about this study


CAREERS AT MICROMET

Micromet looks to recruit the best and brightest in the industry.
Explore current career opportunities

RECENT NEWS

February 15, 2012
Amgen and Micromet Announce Early Termination of HSR Waiting Period for Amgen's Acquisition of Micromet
January 26, 2012
Amgen to Acquire Micromet

UPCOMING EVENTS

© Micromet, Inc. 2010 | Privacy Notice  | Terms of Use  | Imprint  |